Connor, Clark & Lunn Investment Management (CC&L)’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$455K Buy
2025
Q1
$517K Sell
2024
Q4
$682K Sell
2024
Q3
$1.42M Sell
2024
Q2
$1.49M Sell
2024
Q1
$1.53M Buy
2023
Q4
$1.19M Buy
2023
Q3
$971K Buy
2023
Q2
$1.21M Buy
2023
Q1
$459K Buy
2016
Q1
Sell
2015
Q4
$286K Buy
2015
Q1
Sell
2014
Q4
$359K Sell
2014
Q3
$979K Sell
2014
Q2
$1.5M Sell
2014
Q1
$2.05M Buy
2013
Q4
$1.18M Buy